Tajiri K, Shimizu Y. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol. 2017;23(19):3418–26. https://doi.org/10.3748/wjg.v23.i19.3418.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Talwalkar JA, Souto E, Jorgensen RA, et al. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2003;1(4):297–302.

PubMed  Article  Google Scholar 

Fujino H, Tanaka M, Imamura M, et al. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis. BMC Gastroenterol. 2019;19(1):169. https://doi.org/10.1186/s12876-019-1092-z.

Article  PubMed  PubMed Central  Google Scholar 

Kremer AE, Beuers U, Oude-Elferink RP, et al. Pathogenesis and treatment of pruritus in cholestasis. Drugs. 2008;68:2163–82.

CAS  PubMed  Article  Google Scholar 

Kremer AE, Wenniger LM, Oude Elferink RP, et al. Stand van zaken: Pruritus bij leverziekten: pathogenenese en behandeling. Ned Tijdschr Geneeskd. 2011;155:A4045.

PubMed  Google Scholar 

Kremer AE, Oude Elferinck RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35:89–97.

CAS  PubMed  Article  Google Scholar 

Lindor KD, Gerskin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, AASLD practice guidelines. Primary biliairy cirrhosis. Hepatology. 2009;50:291–308.

PubMed  Article  Google Scholar 

Bergasa NV, Mehlman JK, Jones EA. Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(4):643–55.

CAS  PubMed  Article  Google Scholar 

Hegade VS, Bolier R, Oude Elferick RP, et al. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Frontline Gastroenterol. 2016;7(3):158–66.

CAS  PubMed  Article  Google Scholar 

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.

Article  Google Scholar 

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–72.

Article  Google Scholar 

Bergasa NV. The pruritus of cholestasis. J Hepatol. 2005;43(6):1078–88. https://doi.org/10.1016/j.jhep.2005.09.004.

Article  PubMed  Google Scholar 

Bergasa NV. Pruritus of Cholestasis. In: Carstens E, Akiyama T (eds). Itch: Mechanisms and Treatment. Chapter 6. Boca Raton, FL: CRC Press/Taylor & Francis; 2014. https://www.ncbi.nlm.nih.gov/books/NBK200923/. Accessed 12 Jan 2022.

Rishe E, Azarm A, Bergasa NV. Itch in primary biliary cirrhosis: a patients’ perspective. Acta Derm Venereol. 2008;88(1):34–7.

PubMed  Article  Google Scholar 

Oeda S, Takahashi H, Yoshida H, et al. Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res. 2018;48(3):E252–62. https://doi.org/10.1111/hepr.12978.

CAS  Article  PubMed  Google Scholar 

Nakanaga K, Hama K, Aoki J. Autotaxin—an LPA producing enzyme with diverse functions. J Biochem. 2010;148:13–24.

CAS  PubMed  Article  Google Scholar 

Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology. 2012;56(4):1391–400. https://doi.org/10.1002/hep.25748.

CAS  Article  PubMed  Google Scholar 

Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008–18.

CAS  PubMed  Article  Google Scholar 

Yu H, Zhao T, Liu S, et al. MRGPRX4 is a bile acid receptor for human cholestatic itch. Elife. 2019;8: e48431. https://doi.org/10.7554/eLife.48431.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Alemi F, Kwon E, Poole DP, et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest. 2013;123(4):1513–30. https://doi.org/10.1172/JCI64551.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cipriani S, Renga B, D’Amore C, et al. Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signaling. PLoS ONE. 2015;10(7): e0129866. https://doi.org/10.1371/journal.pone.0129866.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hodge RJ, Lin J, Vasist Johnson LS, et al. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clin Pharmacol Drug Dev. 2013;2(3):213–22. https://doi.org/10.1002/cpdd.34.

CAS  Article  PubMed  Google Scholar 

Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch Dermatol. 1974;109(5):678–81.

CAS  PubMed  Article  Google Scholar 

Meixiong J, Vasavda C, Green D, et al. Identification of a bilirubin receptor that may mediate a component of cholestatic itch. Elife. 2019;8: e44116. https://doi.org/10.7554/eLife.44116.

Article  PubMed  PubMed Central  Google Scholar 

Kuiper EM, van Erpecum KJ, Beuers U, et al. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology. 2010;52(4):1334–40. https://doi.org/10.1002/hep.23821.

CAS  Article  PubMed  Google Scholar 

Hegade VS, Krawczyk M, Kremer AE, et al. The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study. Aliment Pharmacol Ther. 2016;43(2):294–302. https://doi.org/10.1111/apt.13449.

CAS  Article  PubMed  Google Scholar 

Sponholz C, Matthes K, Rupp D, et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study. Crit Care. 2016. https://doi.org/10.1186/s13054-015-1159-3.

Article  PubMed  PubMed Central  Google Scholar 

Nieto-Posadas A, Picazo-Juarez G, Llorente I, et al. Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site. Nat Chem Biol. 2012;8:78–85.

CAS  Article  Google Scholar 

Beuers U, Kremer AE, Bolier R, et al. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60(1):399–407. https://doi.org/10.1002/hep.26909.

CAS  Article  PubMed  Google Scholar 

Bergasa NV, Thomas DA, Vergalla J, et al. Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. Life Sci. 1993;53:1253–77.

CAS  PubMed  Article  Google Scholar 

Inan S, Cowan A. Reduced kappa-opioid activity in a rat model of cholestasis. Eur J Pharmacol. 2005;518(2–3):182–6. https://doi.org/10.1016/j.ejphar.2005.06.025.

CAS  Article  PubMed  Google Scholar 

Bergasa NV. The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Med Hypotheses. 2018;110:86–9. https://doi.org/10.1016/j.mehy.2017.11.002.

CAS  Article  PubMed  Google Scholar 

Bergasa NV, Talbot TL, Alling DW, et al. A controlled trial of naloxone infusions for the pruritus of cholestasis. Gastroenterol. 1992;102:544–9.

CAS  Article  Google Scholar 

Bergasa NV, Alling DW, Talbot TL, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind randomised controlled trial. Ann Intern Med. 1995;123:161–7.

CAS  PubMed  Article  Google Scholar 

Bergasa NV, Schmitt JM, Talbot TL, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology. 1998;27:679–84.

CAS  PubMed  Article  Google Scholar 

Bergasa NV, Alling DW, Talbot TL, et al. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Amer Acad Derm. 1999;41:431–4.

CAS  Article  Google Scholar 

Wolfhagen FHJ, Sternieri E, Hop WCJ, et al. Oral naltrexone for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterol. 1997;113:1264–9.

CAS  Article  Google Scholar 

Terg R, Coronel E, Sorda J, et al. Oral naltrexone treatment for cholestatic pruritus: a randomized, double blind, crossover study. Hepatology. 2000;32:167A.

Google Scholar 

Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51(6):787–9. https://doi.org/10.1097/MPG.0b013e3181eb5ac0.

Article  PubMed  Google Scholar 

Mansour-Ghanaei F, Taheri A, Froutan H, et al. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol. 2006;12(7):1125–8. https://doi.org/10.3748/wjg.v12.i7.1125.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Golpanian RS, Yosipovitch G, Levy C. Use of butorphanol as treatment for cholestatic itch. Dig Dis Sci. 2021;66(5):1693–9. https://doi.org/10.1007/s10620-020-06392-2.

CAS  Article  PubMed